These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 10994808)

  • 1. SB-253514 and analogues: novel inhibitors of lipoprotein associated phospholipase A2 produced by Pseudomonas fluorescens DSM 11579. II. Physico-chemical properties and structure elucidation.
    Busby DJ; Copley RC; Hueso JA; Readshaw SA; Rivera A
    J Antibiot (Tokyo); 2000 Jul; 53(7):670-6. PubMed ID: 10994808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SB-253514 and analogues; novel inhibitors of lipoprotein-associated phospholipase A2 produced by Pseudomonas fluorescens DSM 11579. I. Fermentation of producing strain, isolation and biological activity.
    Thirkettle J; Alvarez E; Boyd H; Brown M; Diez E; Hueso J; Elson S; Fulston M; Gershater C; Morata ML; Perez P; Ready S; Sanchez-Puelles JM; Sheridan R; Stefanska A; Warr S
    J Antibiot (Tokyo); 2000 Jul; 53(7):664-9. PubMed ID: 10994807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SB-253514 and analogues; novel inhibitors of lipoprotein associated phospholipase A2 produced by Pseudomonas fluorescens DSM 11579. III. Biotransformation using naringinase.
    Thirkettle J
    J Antibiot (Tokyo); 2000 Jul; 53(7):733-5. PubMed ID: 10994818
    [No Abstract]   [Full Text] [Related]  

  • 4. Natural product derived inhibitors of lipoprotein associated phospholipase A2, synthesis and activity of analogues of SB-253514.
    Pinto IL; Boyd HF; Hickey DM
    Bioorg Med Chem Lett; 2000 Sep; 10(17):2015-7. PubMed ID: 10987439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. (E)-Phenyl- and -heteroaryl-substituted O-benzoyl-(or acyl)oximes as lipoprotein-associated phospholipase A2 inhibitors.
    Jeong TS; Kim MJ; Yu H; Kim KS; Choi JK; Kim SS; Lee WS
    Bioorg Med Chem Lett; 2005 Mar; 15(5):1525-7. PubMed ID: 15713421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. WA8242A1, A2 and B, novel secretary phospholipase A2 inhibitors produced by Streptomyces violaceusniger. III. Structure elucidation and total synthesis of WA8242B.
    Yoshimura S; Otsuka T; Takase S; Okamoto M; Okada S; Hemmi K
    J Antibiot (Tokyo); 1998 Jul; 51(7):655-64. PubMed ID: 9727392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 2-(Alkylthio)pyrimidin-4-ones as novel, reversible inhibitors of lipoprotein-associated phospholipase A2.
    Boyd HF; Flynn ST; Hickey DM; Ife RJ; Jones M; Leach CA; Macphee CH; Milliner KJ; Rawlings DA; Slingsby BP; Smith SA; Stansfield IG; Tew DG; Theobald CJ
    Bioorg Med Chem Lett; 2000 Feb; 10(4):395-8. PubMed ID: 10714508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The identification of clinical candidate SB-480848: a potent inhibitor of lipoprotein-associated phospholipase A2.
    Blackie JA; Bloomer JC; Brown MJ; Cheng HY; Hammond B; Hickey DM; Ife RJ; Leach CA; Lewis VA; Macphee CH; Milliner KJ; Moores KE; Pinto IL; Smith SA; Stansfield IG; Stanway SJ; Taylor MA; Theobald CJ
    Bioorg Med Chem Lett; 2003 Mar; 13(6):1067-70. PubMed ID: 12643913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potent synthetic inhibitors of tyrosyl tRNA synthetase derived from C-pyranosyl analogues of SB-219383.
    Jarvest RL; Berge JM; Brown P; Hamprecht DW; McNair DJ; Mensah L; O'Hanlon PJ; Pope AJ
    Bioorg Med Chem Lett; 2001 Mar; 11(5):715-8. PubMed ID: 11266176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conformationally restricted (+)-cacospongionolide B analogues. Influence on secretory phospholipase A2 inhibition.
    Murelli RP; Cheung AK; Snapper ML
    J Org Chem; 2007 Mar; 72(5):1545-52. PubMed ID: 17315974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-1 substituted pyrimidin-4-ones: novel, orally active inhibitors of lipoprotein-associated phospholipase A2.
    Boyd HF; Fell SC; Flynn ST; Hickey DM; Ife RJ; Leach CA; Macphee CH; Milliner KJ; Moores KE; Pinto IL; Porter RA; Rawlings DA; Smith SA; Stansfield IG; Tew DG; Theobald CJ; Whittaker CM
    Bioorg Med Chem Lett; 2000 Nov; 10(22):2557-61. PubMed ID: 11086729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonribosomal assembly of natural lipocyclocarbamate lipoprotein-associated phospholipase inhibitors.
    Johnston CW; Zvanych R; Khyzha N; Magarvey NA
    Chembiochem; 2013 Mar; 14(4):431-5. PubMed ID: 23401283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthetic analogues of SB-219383. Novel C-glycosyl peptides as inhibitors of tyrosyl tRNA synthetase.
    Brown P; Eggleston DS; Haltiwanger RC; Jarvest RL; Mensah L; O'Hanlon PJ; Pope AJ
    Bioorg Med Chem Lett; 2001 Mar; 11(5):711-4. PubMed ID: 11266175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Indole inhibitors of human nonpancreatic secretory phospholipase A2. 1. Indole-3-acetamides.
    Dillard RD; Bach NJ; Draheim SE; Berry DR; Carlson DG; Chirgadze NY; Clawson DK; Hartley LW; Johnson LM; Jones ND; McKinney ER; Mihelich ED; Olkowski JL; Schevitz RW; Smith AC; Snyder DW; Sommers CD; Wery JP
    J Med Chem; 1996 Dec; 39(26):5119-36. PubMed ID: 9005255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Indole inhibitors of human nonpancreatic secretory phospholipase A2. 2. Indole-3-acetamides with additional functionality.
    Dillard RD; Bach NJ; Draheim SE; Berry DR; Carlson DG; Chirgadze NY; Clawson DK; Hartley LW; Johnson LM; Jones ND; McKinney ER; Mihelich ED; Olkowski JL; Schevitz RW; Smith AC; Snyder DW; Sommers CD; Wery JP
    J Med Chem; 1996 Dec; 39(26):5137-58. PubMed ID: 8978843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The identification of a potent, water soluble inhibitor of lipoprotein-associated phospholipase A2.
    Boyd HF; Hammond B; Hickey DM; Ife RJ; Leach CA; Lewis VA; Macphee CH; Milliner KJ; Pinto IL; Smith SA; Stansfield IG; Theobald CJ; Whittaker CM
    Bioorg Med Chem Lett; 2001 Mar; 11(5):701-4. PubMed ID: 11266173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipoprotein-associated phospholipase A2, platelet-activating factor acetylhydrolase, generates two bioactive products during the oxidation of low-density lipoprotein: use of a novel inhibitor.
    MacPhee CH; Moores KE; Boyd HF; Dhanak D; Ife RJ; Leach CA; Leake DS; Milliner KJ; Patterson RA; Suckling KE; Tew DG; Hickey DM
    Biochem J; 1999 Mar; 338 ( Pt 2)(Pt 2):479-87. PubMed ID: 10024526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. X-ray structure of phospholipase A2 complexed with a substrate-derived inhibitor.
    Thunnissen MM; Ab E; Kalk KH; Drenth J; Dijkstra BW; Kuipers OP; Dijkman R; de Haas GH; Verheij HM
    Nature; 1990 Oct; 347(6294):689-91. PubMed ID: 2215698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Total syntheses of (+)- and (-)-cacospongionolide B, cacospongionolide e, and related analogues. Preliminary study of structural features required for phospholipase a2 inhibition.
    Cheung AK; Murelli R; Snapper ML
    J Org Chem; 2004 Aug; 69(17):5712-9. PubMed ID: 15307744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-resolution X-ray crystallography reveals precise binding interactions between human nonpancreatic secreted phospholipase A2 and a highly potent inhibitor (FPL67047XX).
    Cha SS; Lee D; Adams J; Kurdyla JT; Jones CS; Marshall LA; Bolognese B; Abdel-Meguid SS; Oh BH
    J Med Chem; 1996 Sep; 39(20):3878-81. PubMed ID: 8831753
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.